A study by the Brazilian Institute for Consumer Protection (Idec), entitled "The Size of the Gap: Comparison between the Price Ceiling of Medicines in Pharmacies and through the SUS (Brazilian Public Health System)," reveals significant flaws in the drug price regulation model in Brazil. The study demonstrates that the maximum prices authorized by the Chamber for the Regulation of the Medicines Market (CMED), an agency linked to Anvisa (Brazilia…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
A study by the Brazilian Institute for Consumer Protection (Idec), entitled "The Size of the Gap: Comparison between the Price Ceiling of Medicines in Pharmacies and through the SUS (Brazilian Public Health System)," reveals significant flaws in the drug price regulation model in Brazil. The study demonstrates that the maximum prices authorized by the Chamber for the Regulation of the Medicines Market (CMED), an agency linked to Anvisa (Brazilia…